Walgreens Boots Alliance Inc (NASDAQ:WBA) announced a quarterly dividend on Wednesday, July 10th, Zacks reports. Investors of record on Tuesday, August 20th will be given a dividend of 0.458 per share by the pharmacy operator on Thursday, September 12th. This represents a $1.83 annualized dividend and a dividend yield of 3.63%. The ex-dividend date is Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44.
Walgreens Boots Alliance has raised its dividend payment by an average of 6.4% annually over the last three years and has increased its dividend annually for the last 43 consecutive years. Walgreens Boots Alliance has a payout ratio of 30.6% meaning its dividend is sufficiently covered by earnings. Research analysts expect Walgreens Boots Alliance to earn $6.01 per share next year, which means the company should continue to be able to cover its $1.83 annual dividend with an expected future payout ratio of 30.4%.
WBA stock opened at $50.48 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The business has a 50-day moving average price of $54.18 and a 200 day moving average price of $57.57. The company has a market capitalization of $44.52 billion, a P/E ratio of 8.15, a PEG ratio of 1.23 and a beta of 0.81. Walgreens Boots Alliance has a 1-year low of $49.12 and a 1-year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.05. The firm had revenue of $34.59 billion during the quarter, compared to the consensus estimate of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The firm’s quarterly revenue was up .7% on a year-over-year basis. During the same period in the previous year, the company posted $1.53 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance will post 5.99 earnings per share for the current fiscal year.
Several analysts recently weighed in on WBA shares. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. Morgan Stanley set a $61.00 price objective on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Tuesday, May 14th. Bank of America decreased their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a report on Monday, June 3rd. JPMorgan Chase & Co. decreased their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a report on Friday, June 28th. Finally, Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective for the company. in a report on Monday, June 10th. Six equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $63.82.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the transaction, the chief accounting officer now owns 357,851 shares in the company, valued at $18,064,318.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 15.73% of the stock is owned by insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Different Options Trading Strategies
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.